AP NEWS

Global Vitiligo Market to 2024: Patients by Countries, Drugs, Companies, Clinical Study, Growth Drivers, and Challenges - ResearchAndMarkets.com

December 18, 2018

DUBLIN--(BUSINESS WIRE)--Dec 18, 2018--The “Global Vitiligo Market, Patients by Countries, Drugs, Companies, Clinical Study, Growth Drivers, and Challenges” report has been added to ResearchAndMarkets.com’s offering.

Global Vitiligo market will be US$ 2.4 Billion by the year 2024

Vitiligo is a long-term skin disease in which patches of the skin lose their color. The skin patches affected by the disease Vitiligo become white. This happens because melanocytes within the skin die off. The skin pigmentation, melanin, due to which skin has its color, protection from solar UV rays this all happens because of melanocytes cells.

Growing per capita healthcare expenditure, improving healthcare infrastructure in developing countries, growing diseases awareness and expected approval of Vitiligo drugs are some of the driving force for the growth of this market. However, the shortage of dermatologists and available treatments having a longer duration of times are major challenges for the growth of this market.

Vitiligo disease prevalence varies between race, regions, and countries. It is expected that overall prevalence falls between 1-2 percent of the total population. Although Vitiligo disease can arise at any age, it mostly occurs to young and middle age people. At present globally over 21 Million people have suffered from this disease.

There is a number of drugs manufacture working for Vitiligo drugs development across various parts of the globe such as AXIM Biotechnologies, Boston Pharmaceutical, Castle Creek Pharma, Dermavant Sciences, JN Biosciences, Bristol-Myers Squibb, Incyte Corporation, Clinuvel Pharmaceuticals etc. and their Vitiligo drugs development are in various stages.

Key Topics Covered:

1. Introduction

2. Research Methodology

3. Executive Summary

4. Global Vitiligo Patient Numbers & Market

5. Share - Global Vitiligo Patient Numbers & Market

6. United States

7. United Kingdom

8. France

9. Germany

10. Italy

11. India

12. China

13. Japan

14. Vitiligo Pipe Line Drugs

15. Clinical Study of Vitiligo Market

16. Growth Drivers

17. Global Vitiligo Market - Challenges

18. AXIM Biotechnologies, Inc.

19. Incyte Corporation

20. Bristol-Myers Squibb

21. Clinuvel Pharmaceuticals Ltd

For more information about this report visit https://www.researchandmarkets.com/research/mwpmq2/global_vitiligo?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181218005426/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Immune Disorders Drugs,Dermatological Drugs

KEYWORD:

INDUSTRY KEYWORD: HEALTH PHARMACEUTICAL

SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 12/18/2018 07:26 AM/DISC: 12/18/2018 07:26 AM

http://www.businesswire.com/news/home/20181218005426/en

AP RADIO
Update hourly